Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

80.21
-0.8600-1.06%
Volume:1.05M
Turnover:84.76M
Market Cap:15.71B
PE:-22.48
High:82.50
Open:81.89
Low:80.20
Close:81.07
52wk High:93.42
52wk Low:47.26
Shares:195.81M
Float Shares:167.00M
Volume Ratio:0.49
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-6.24
PE(LYR):-21.19

Loading ...

BridgeBio price target lowered to $97 from $98 at Morgan Stanley

TIPRANKS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11

C4 Therapeutics Q2 Revenue Beats Estimates, Helped by Roche Collaboration

Reuters
·
Aug 11

Wells Fargo Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TIPRANKS
·
Aug 11

Morgan Stanley Adjusts PT on BridgeBio Pharma to $97 From $98, Maintains Overweight Rating

MT Newswires Live
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Aug 11

BridgeBio Pharma, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

BridgeBio Pharma Q2 Loss Narrows, Revenue Rises

MT Newswires Live
·
Aug 11

Earnings Flash (BBIO) BridgeBio Pharma Posts Q2 Loss $0.78, vs. FactSet Est of $0.58 Loss

MT Newswires Live
·
Aug 11

BridgeBio Pharma Q2 EPS $(0.78) Misses $(0.59) Estimate, Sales $243.676M Beat $218.743M Estimate

Benzinga Earnings
·
Aug 11

BridgeBio Pharma Q2 Net Income USD -155.891 Million

Reuters
·
Aug 11

BridgeBio Pharma Q2 EPS USD -0.78

THOMSON REUTERS
·
Aug 11

U.S. Earnings Preview: After Market Close Aug. 10

Dow Jones
·
Aug 11

BridgeBio Pharma, Inc. Expected to Post a Loss of 58 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 07

BridgeBio Pharma Chief Accounting Officer Maricel Apuli Sells 2,000 Shares for $160,120

Reuters
·
Aug 04

BridgeBio Pharma to Report Q2 Financial Results, Provide Business Update on Conference Call

Reuters
·
Aug 03

BridgeBio (BBIO) Stock Still Looks Pricey After FDA Filing Acceptance

Simply Wall St.
·
Jul 29

BridgeBio Oncology Therapeutics Inc Expected to Post a Loss of 57 Cents a Share - Earnings Preview

Reuters
·
Jul 28